Skip to main content

Rohit Mistry, MPharm, MBA, MSc

Authored Items
Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective
Kenneth LaPensee, PhD, MPH, Rohit Mistry, MPharm, MBA, MSc, Thomas Lodise, PhD, PharmD
February 2019, Vol 12, No 1, Supplement 1: Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective in Pulmonary
Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections
Kenneth LaPensee, PhD, MPH, Rohit Mistry, MPharm, MBA, MSc, Thomas Lodise, PhD, PharmD
February 2019, Vol 12, No 1, Supplement 2: Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections
Last modified: February 11, 2019